Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forman

Showing results (901-910 of 1,052) with videos related to

Pageof 106
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignanciesG D Long, M D Amylon, K E Stockerl-Goldstein, et al.
Blood Advances|September 28, 2021
Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label studyHaris Ali, Ni-Chun Tsai, Timothy Synold, et al.
JAMA Oncology|July 29, 2018
Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in ChildhoodAnna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Blood|November 11, 2006
End points to establish the efficacy of new agents in the treatment of acute leukemiaFrederick R Appelbaum, Daniel Rosenblum, Robert J Arceci, et al.
Science Translational Medicine|March 6, 2020
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastomaDongrui Wang, Renate Starr, Wen-Chung Chang, et al.
Science Translational Medicine|June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphomaDavid L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Blood|July 2, 2011
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic miceSimon F Lacey, Corinna La Rosa, Teodora Kaltcheva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remissionA S Stein, M R O'Donnell, A Chai, et al.
Blood|May 30, 2008
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsBrian G Till, Michael C Jensen, Jinjuan Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2024
Sex-Based Differences in Risk of Therapy-Related Myeloid NeoplasmsMelissa A Richard, Chengcheng Yan, Yanjun Chen, et al.
Pageof 106

Showing results (901-910 of 1,052) with videos related to

Sort By:
Pageof 106
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignanciesG D Long, M D Amylon, K E Stockerl-Goldstein, et al.
Blood Advances|September 28, 2021
Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label studyHaris Ali, Ni-Chun Tsai, Timothy Synold, et al.
JAMA Oncology|July 29, 2018
Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in ChildhoodAnna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Blood|November 11, 2006
End points to establish the efficacy of new agents in the treatment of acute leukemiaFrederick R Appelbaum, Daniel Rosenblum, Robert J Arceci, et al.
Science Translational Medicine|March 6, 2020
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastomaDongrui Wang, Renate Starr, Wen-Chung Chang, et al.
Science Translational Medicine|June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphomaDavid L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Blood|July 2, 2011
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic miceSimon F Lacey, Corinna La Rosa, Teodora Kaltcheva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remissionA S Stein, M R O'Donnell, A Chai, et al.
Blood|May 30, 2008
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsBrian G Till, Michael C Jensen, Jinjuan Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2024
Sex-Based Differences in Risk of Therapy-Related Myeloid NeoplasmsMelissa A Richard, Chengcheng Yan, Yanjun Chen, et al.
Pageof 106